CELLDEMIC Trademark

Trademark Overview

On Wednesday, July 26, 2023, a trademark application was filed for CELLDEMIC with the United States Patent and Trademark Office. The USPTO has given the CELLDEMIC trademark a serial number of 98103041. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, January 29, 2026. This trademark is owned by Seqirus UK Limited. The CELLDEMIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations to treat and prevent influenza, pharmaceutical preparations to treat and prevent respiratory disease, vaccines
celldemic

General Information

Serial Number98103041
Word MarkCELLDEMIC
Filing DateWednesday, July 26, 2023
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, January 29, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations to treat and prevent influenza, pharmaceutical preparations to treat and prevent respiratory disease, vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSeqirus UK Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMaidenhead, Berkshire SL68AA
GB
Party NameSeqirus UK Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMaidenhead, Berkshire SL68AA
GB

Trademark Events

Event DateEvent Description
Saturday, July 29, 2023NEW APPLICATION ENTERED
Tuesday, August 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 1, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 1, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 11, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, January 31, 2024ASSIGNED TO LIE
Thursday, February 1, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 1, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, February 12, 2024ASSIGNED TO EXAMINER
Monday, February 12, 2024NON-FINAL ACTION WRITTEN
Monday, February 12, 2024NON-FINAL ACTION E-MAILED
Monday, February 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 22, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 11, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 11, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 6, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 27, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, February 5, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, January 27, 2025SOU EXTENSION 1 FILED
Tuesday, January 28, 2025SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 29, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 29, 2025SOU EXTENSION 2 FILED
Tuesday, July 29, 2025SOU EXTENSION 2 GRANTED
Wednesday, July 30, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 29, 2026SOU TEAS EXTENSION RECEIVED
Thursday, January 29, 2026SOU EXTENSION 3 FILED
Thursday, January 29, 2026SOU EXTENSION 3 GRANTED
Friday, January 30, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

celldemic pharmaceutical treat prevent preparations vaccines disease respiratory influenza